Market Cap
$4.7B
ABCL
AbCellera Biologics Inc.
$13.74 ▼ -1.22%
Prev close $13.91Market cap$4.7B
ConsensusStrong Buy
12-mo target$16.70 (+21.5%)
▲ Bullish
Analyst conviction 9/10
Insider Buying Cluster (3 insiders)High Impact Filing (7/10)14 New Institutional Positions20 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on ABCL right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (93%)
Inst. Holders
50 funds
Inst. Value
$861.2M
Inst. Activity
14 buys / 20 sells
Insider Activity
$1.9M buy / $0.00 sell
Insider Net $
$1.9M
Social Sentiment
70° Bullish
SEC Reports
12
Price chart 30d +18.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Aug 25, 2026 SEC Short Volume: ABCL — 56.5% short (2.0M / 3.6M)
Short: 2,025,897 | Exempt: 13,603 | TRF Vol: 3,586,664 | Short Ratio: 56.5% | Off-exchange volume (d
Two directors at AbCellera made open-market purchases totaling $681K, with the largest buy ($570K) occurring 13 days aft
CLUSTER — Impact 5/10
Aug 24, 2026 Insider
Aug 18, 2026 SEC Hayden Michael R bought 53,613 shares
Director @ $10.64 ($570.4K)
Three AbCellera insiders, including the CFO and two directors, purchased a total of ~$975K in open-market shares over a
CLUSTER — Impact 5/10
Aug 18, 2026 Insider
Aug 15, 2026 SEC Montalbano John S. bought 10,000 shares
Director @ $11.03 ($110.3K)
AbCellera Biologics (ABCL) saw a mixed institutional cluster in Q2 2026: 5 buyers added $51.3M in new positions (dominat
INST-CLUSTER — Impact 6/10
Aug 14, 2026 Insider
Booth Andrew bought 37,200 shares
Chief Financial Officer @ $10.32 ($383.9K)
Jun 30, 2026 Inst.
BANK OF AMERICA CORP — DOUBLED
6,141,539 shares ($48.2M)
Analyst ratings buy % +8.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
93% rate it Buy or better · 15 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 29, 2026 | JP Morgan | INITIATE | Overweight | 55% |
| Aug 11, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| Aug 6, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Aug 6, 2026 | Cantor Fitzgerald | MAINTAIN | Overweight | 49% |
| Jul 7, 2026 | Benchmark | UPGRADE | Buy | 54% |
| May 5, 2026 | Cantor Fitzgerald | INITIATE | Overweight | 49% |
| Apr 10, 2026 | Jones Trading | INITIATE | Buy | 51% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 11 | 1 | 0 | 0 | 93% | |
| Aug 1, 2026 | 3 | 11 | 1 | 0 | 0 | 93% | |
| Jul 1, 2026 | 3 | 10 | 2 | 0 | 0 | 87% | |
| Jun 1, 2026 | 3 | 10 | 2 | 0 | 0 | 87% | |
| May 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Mar 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Feb 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% |
Price targets
Where 10 covering analysts think ABCL trades over the next 12 months.
$16.70 +21.5% upside Strong Buy
Current$13.74 Low$9.00 Median$15.00 High$30.00 10 analysts
$9.00$30.00
Analyst rating Strong Buy· 1.4/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
70°
Bullish
BearishNeutralBullish
Recent posts
I created a Telegram channel dedicated to AbCellera ($ABCL)
▲ 1 · 💬 0· ⚡ 0.5
ABCL Gains
▲ 1 · 💬 7· ⚡ 0.5
ABCL Gains
▲ 1 · 💬 0· ⚡ 0.5
$ABCL My Easy 2x Took the Long Hard Road but Eventually Got There. Now I Think $15 Is Next - DD
▲ 1 · 💬 10· ⚡ 0.5
ABCL gainz. Prepping for the next one! No options this time. maybe 1.1x leverage.
▲ 1 · 💬 0· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
12 SEC filing reports analyzed · 6 bullish, 2 bearish, 1 mixed, 3 neutral · avg impact 5.1/10.
MIXEDCLUSTER5/10
Two directors at AbCellera made open-market purchases totaling $681K, with the largest buy ($570K) o
Aug 25, 2026
BULLISHCLUSTER5/10
Three AbCellera insiders, including the CFO and two directors, purchased a total of ~$975K in open-m
Aug 18, 2026
BEARISHINST-CLUSTER6/10
AbCellera Biologics (ABCL) saw a mixed institutional cluster in Q2 2026: 5 buyers added $51.3M in ne
Aug 15, 2026
BEARISH424B57/10
AbCellera Biologics Inc. filed a preliminary prospectus supplement for a $200 million underwritten p
Aug 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: ABCL — 56.5% short (2.0M / 3.6M)
Short: 2,025,897 | Exempt: 13,603 | TRF Vol: 3,586,664 | Short Ratio: 56.5% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: ABCL — 55.3% short (1.9M / 3.4M)
Short: 1,866,483 | Exempt: 4,115 | TRF Vol: 3,374,903 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: ABCL — 59.1% short (1.1M / 1.8M)
Short: 1,070,775 | Exempt: 661 | TRF Vol: 1,812,828 | Short Ratio: 59.1% | Off-exchange volume (dark pool + OTC)
Aug 31, 2026
short_volume
Short Volume: ABCL — 64.0% short (1.3M / 2.1M)
Short: 1,323,508 | Exempt: 13,410 | TRF Vol: 2,069,045 | Short Ratio: 64.0% | Off-exchange volume (dark pool + OTC)
Aug 26, 2026
ftd
FTD: ABCL — 82,773 shares ($1.0M) failed to deliver
Settlement: 20260826, Price: $12.50, FTD Value: $1,034,662.5, ABCELLERA BIOLOGICS INC. (CAN)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.18 | $-0.20–$-0.16 | 7.4% | -1.5% | 1↑ 0↓ | $0.0B | 5 |
| Next Q | $-0.18 | $-0.20–$-0.15 | -493.3% | -4.7% | 2↑ 1↓ | $0.0B | 5 |
| Current FY | $-0.68 | $-0.73–$-0.63 | -38.2% | -3.2% | 1↑ 3↓ | $0.0B | 7 |
| Next FY | $-0.78 | $-0.96–$-0.56 | -15.2% | -9.1% | 2↑ 1↓ | $0.0B | 6 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.176 | — |
| 7d ago | $-0.173 | -0.003 |
| 30d ago | $-0.173 | -0.003 |
| 60d ago | $-0.175 | -0.001 |
| 90d ago | $-0.175 | -0.001 |
Institutional ownership
Which big funds own ABCL (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $861.2M total value (110,019,343 shares) as of 2026-Q2. Top holders: BAKER, Capital, TWO. Net selling activity: 20 institutions trimmed/exited vs 14 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 33,012,138 | $259.1M | 30.1% | — |
| Capital World Investors | 13,588,349 | $106.7M | 12.4% | — |
| TWO SIGMA INVESTMENTS, LP | 10,437,431 | $81.9M | 9.5% | — |
| TD Waterhouse Canada Inc. | 9,568,149 | $72.6M | 8.4% | DOUBLED +42576.5% |
| BANK OF AMERICA CORP /DE/ | 6,141,539 | $48.2M | 5.6% | DOUBLED +104.7% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4,317,206 | $33.9M | 3.9% | TRIM -43.0% |
| BlackRock, Inc. | 3,805,309 | $29.9M | 3.5% | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,886,000 | $22.7M | 2.6% | NEAR_EXIT -97.3% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,864,729 | $22.5M | 2.6% | TRIM -28.8% |
| TUDOR INVESTMENT CORP ET AL | 2,063,191 | $16.2M | 1.9% | ADD +26.6% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | 2,999,936 | 6,141,539 | +104.7% | $48.2M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | TRIM | 7,575,476 | 4,317,206 | -43.0% | $33.9M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | TRIM | 4,024,779 | 2,864,729 | -28.8% | $22.5M |
| MARSHALL WACE, LLP | DOUBLED | 359,683 | 1,902,191 | +428.9% | $14.9M |
| UBS Group AG | TRIM | 4,209,052 | 1,870,633 | -55.6% | $14.7M |
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | 1,393 | 1,233,014 | +88415.0% | $9.7M |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 1,510,629 | 990,929 | -34.4% | $7.8M |
| Alyeska Investment Group, L.P. | NEAR_EXIT | 2,592,105 | 526,577 | -79.7% | $4.1M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 1,294,574 | 518,571 | -59.9% | $4.1M |
| BANK OF MONTREAL /CAN/ | DOUBLED | 181,690 | 482,799 | +165.7% | $3.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
7 insiders, 14 transactions. Net $1.9M — $1.9M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Hayden Michael R | Director | BUY | 53,613 | $10.64 | $570.4K |
| Aug 18, 2026 | Montalbano John S. | Director | BUY | 10,000 | $11.03 | $110.3K |
| Aug 14, 2026 | Booth Andrew | Chief Financial Officer | BUY | 37,200 | $10.32 | $383.9K |
| Aug 12, 2026 | Hayden Michael R | Director | BUY | 46,387 | $10.37 | $481.0K |
| Aug 11, 2026 | Hayden Michael R | Director | GIFT | 50,000 | — | — |
| Jul 1, 2026 | Seely Lynn | Director | AWARD | 152,207 | — | — |
| Jul 1, 2026 | Sandor Victor | Director | AWARD | 152,207 | — | — |
| Jun 11, 2026 | Montalbano John S. | Director | AWARD | 111,701 | — | — |
| Jun 11, 2026 | Quake Stephen | Director | AWARD | 111,701 | — | — |
| Jun 11, 2026 | Hayden Michael R | Director | AWARD | 111,701 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ABCL.
Shares short
33,930,287
Settlement Sep 15, 2026
Change vs prior
-2.4%
Semi-monthly cycle
Days to cover
9.6
At avg daily volume
Of shares outstanding
≈10.5%
Estimate — not % of float
All ABCL filing & press-release reports (12)
- CLUSTER reportAug 25, 2026
- CLUSTER reportAug 18, 2026
- INST-CLUSTER reportAug 15, 2026
- 424B5 reportAug 11, 2026
- 8-K reportAug 10, 2026
- 8-K reportJul 29, 2026
- 3 reportJul 6, 2026
- 8-K reportJul 6, 2026
- 8-K reportJun 5, 2026
- 8-K reportMay 11, 2026
- CLUSTER reportMar 2, 2026
- 8-K reportFeb 24, 2026